De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(19 sites)
United States
University of Alabama & Children's Hospital of Alabama (UAB-CoA), Birmingham, Alabama University of Arkansas & Arkansas Children's Hospital (UA-ACH), Little Rock, Arkansas University of California-Irvine & Children's Hospital of Orange County (UC-CHOC), Irvine, California University of Southern California & Children's Hospital Los Angeles (USC-CHLA), Los Angeles, California Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH), Palo Alto, California University of California, San Diego & Rady Children's Hospital (UCSD-Rady), San Diego, California University of Colorado & Children's Hospital of Colorado (CU-CHC), Aurora, Colorado Emory University & Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia Indiana University & Riley Children's Hospital (IU-RiCH), Indianapolis, Indiana University of Louisville & Norton Children's Hospital (UL-NCH), Louisville, Kentucky Harvard University & Boston Children's Hospital (Harvard-BCH), Boston, Massachusetts University of Michigan & CS Mott Children's Hospital (UM-CSMott), Ann Arbor, Michigan Randall Children's Hospital-Portland (RCH), Portland, Oregon Medical University of South Carolina Children's Health (MUSC), Charleston, South Carolina University of Tennessee & LeBonheur Children's Hospital (UT-LBCH), Memphis, Tennessee Vanderbilt University & Vanderbilt University Medical Center (VUMC), Nashville, Tennessee The University of Texas Health Science Center at Houston, Houston, Texas University of Utah & Primary Children's Hospital (Utah-PCH), Salt Lake City, Utah University of Washington & Seattle Children's Hospital (UW-SCH), Seattle, Washington Age range
0 Months – 1 Month
Last updated February 2026